@article{fd9e5a3f928c482595bbd566a36d4e94,
title = "Cognitive dysfunction in systemic lupus erythematosus: how do we advance our understanding?",
author = "Sudha Raghunath and Yifat Glikmann-Johnston and Hanly, {John G.} and Morand, {Eric F.} and Stout, {Julie C.} and Alberta Hoi",
note = "Funding Information: EFM reports grants from the National Health and Medical Research Council, Australia, during the conduct of the study; grants and personal fees from AstraZeneca, Bristol Myers Squibb, Eli Lilly, Janssen, Wolf, GlaxoSmithKline, and EMD Serono; and personal fees from Biogen, AbbVie, Neovacs, Sanofi, UCB, Novartis, and Amgen; all of which were outside the submitted work. JCS is a director of Zindametrix, which provides cognitive assessment advice and assists in the implementation of cognitive testing in commercial and academic clinical trials in Huntington's disease; she also conducts professional consultation in neuropsychology and cognitive testing via Stout Neuropsych. AH reports grants from AstraZeneca and Merck Serono outside the submitted work, sponsorship of the Australian Lupus Registry and Biobank which is chaired by AH is received from Janssen, BMS, and UCB and honorarium from AbbVie. All other authors declare no competing interests. Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",
year = "2022",
month = apr,
doi = "10.1016/S2665-9913(21)00331-3",
language = "English",
volume = "4",
pages = "e293--e302",
journal = "The Lancet Rheumatology",
issn = "2665-9913",
publisher = "Lancet Publishing Group",
number = "4",
}